By Sri Hari N S and Bhanvi Satija Feb 26 (Reuters) - British generic drugmaker Hikma Pharmaceuticals scrapped its medium-term targets as it forecast slower annual revenue growth and profit on Thursday ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Paradise returns for its second season with new locations, new characters, and more secrets. It was a lot to digest, and we’re talking about it right here.

Shares fell by more than 15% on results showing study participants receiving Novo’s CagriSema lost less weight than those who took Lilly’s Zepbound.

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

Doctors call Wegovy’s new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly 200,000 people ...

Donna Kelce is clarifying how she slimmed down before The Traitors season 4 reunion. After the “Kelce Brothers” fan account ...

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...

Can the British monarchy survive the Andrew crisis? Plus Why so few foresaw Putin’s war ...

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Tariffs are increasingly a function of political cycles and their fallout. India’s negotiations are now undergirded by a coherent doctrine that builds on its core economic strengths ...